Immunological look at the treatment of coronavirus COVID-19 and SARS-2 infections
The article outlines the causes of deaths when using a combination of azithromycin with Plaquenil®. Immunological substantiation of the main factors leading to vascular and pulmonary pathology (triggering angiotensin-converting enzyme and helper aggression in the lungs) is given. An immunotherapy method that eliminates the etiological links of the processes occurring during COVID-19 viremia is proposed. The method of prophylaxis of personnel in contact with patients is to use specific antibodies to coronaviruses found in immunoglobulin with intramuscular injection. A treatment schema for severe patients with COVID-19, SARS-2 is proposed.
Stasevich K. Zhizn' i ustrojstvo koronavirusov // Nauka i zhizn'. – 2020. – № 4. – Р. 8–13.
COVID-19: Rannie epidemiologicheskie i klinicheskie issledovaniya dlya obshchestvennogo zdravoohraneniya Informaciya nv veb-sajte VOZ: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations
Shirobokov V. P. Medicinskaya mikrobiologiya, virusologiya i immunologiya. – Vinnica : Nova Kniga, 2015. – S. 504–505.
Shchelkanov M. Yu., Popova A. Yu., Dedkov V. G. i dr. Istoriya izucheniya i sovremennaya klassifikaciya koronavirusov (Nidovirales: Coronaviridae) // Infekciya i immunitet. – 2020. – T. 10, № 2. – S. 221–246.
Virus Metadata Repository: version May 1, 2020; MSL35 // International Committee on Taxonomy of Viruses (ICTV). – 2020. – 1 May.
Abstract views: 158 PDF Downloads: 740
This work is licensed under a Creative Commons Attribution 4.0 International License.